| Mankind Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543904 |
NSE Symbol : MANKIND |
P/E(TTM) : 44.39 |
|
ISIN Demat : INE634S01028 |
Div & Yield% : 0.04 |
EPS(TTM) : 54.76 |
|
Book Value(₹) : 397.02 |
Market Cap(₹Cr) : 100,395.19 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10,421.18 | 9,507.41 | 8,629.25 | 8,127.15 | 7,486.22 |
| Other Income | 326.10 | 554.65 | 374.03 | 162.78 | 203.81 |
| Stock Adjustments | -35.37 | 13.68 | 48.20 | -267.89 | 365.27 |
| Total Income | 10,711.91 | 10,075.74 | 9,051.48 | 8,022.04 | 8,055.30 |
| EXPENDITURE : | |||||
| Raw Materials | 2,589.80 | 2,618.16 | 2,618.31 | 2,576.87 | 2,886.71 |
| Power and Fuel Cost | 97.78 | 89.14 | 80.91 | 62.00 | 60.36 |
| Other Manufacturing Expenses | 234.66 | 211.70 | 145.78 | 113.62 | 93.57 |
| Selling and Administration Expenses | 1,905.45 | 1,773.61 | 1,518.78 | 1,539.07 | 1,378.52 |
| Miscellaneous Expenses | 211.11 | 254.27 | 125.69 | 168.47 | 131.08 |
| Employee Benefit Expenses | 2,367.04 | 2,148.87 | 1,921.09 | 1,701.38 | 1,462.76 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 3,306.07 | 2,979.99 | 2,640.92 | 1,860.65 | 2,042.30 |
| Interest | 562.50 | 377.50 | 16.93 | 28.23 | 47.54 |
| Gross Profit | 2,743.57 | 2,602.49 | 2,623.99 | 1,832.42 | 1,994.76 |
| Depreciation | 428.57 | 394.76 | 335.26 | 269.58 | 123.33 |
| Profit Before Tax | 2,315.00 | 2,207.73 | 2,288.73 | 1,562.84 | 1,871.43 |
| Current Tax | 473.22 | 469.93 | 411.33 | 291.64 | 429.03 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -195.78 | -48.19 | 1.24 | 22.94 | 52.98 |
| Reported Net Profit | 2,037.56 | 1,785.99 | 1,876.16 | 1,248.26 | 1,389.42 |
| Extraordinary Items | -87.60 | 180.81 | 105.89 | 29.02 | 62.07 |
| Adjusted Net Profit | 2,125.16 | 1,605.18 | 1,770.27 | 1,219.24 | 1,327.35 |
| Adjustment below Net Profit | 38.21 | -153.08 | -6.66 | -4.86 | -0.79 |
| Profit/Loss Balance carried down | 11,396.88 | 9,763.97 | 7,894.47 | 6,624.90 | 5,236.27 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 41.27 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 13,431.38 | 11,396.88 | 9,763.97 | 7,868.30 | 6,624.90 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 49.36 | 43.29 | 46.83 | 31.16 | 34.68 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 397.21 | 347.13 | 242.21 | 194.31 | 163.27 |
| Book Value(Adj)-Unit Curr | 397.21 | 347.13 | 242.21 | - | - |
